ADALAT CC Drug Patent Profile
✉ Email this page to a colleague
When do Adalat Cc patents expire, and what generic alternatives are available?
Adalat Cc is a drug marketed by Norwich and is included in one NDA.
The generic ingredient in ADALAT CC is nifedipine. There are thirty-nine drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the nifedipine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Adalat Cc
A generic version of ADALAT CC was approved as nifedipine by ACTAVIS ELIZABETH on September 20th, 1990.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ADALAT CC?
- What are the global sales for ADALAT CC?
- What is Average Wholesale Price for ADALAT CC?
Summary for ADALAT CC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 165 |
Clinical Trials: | 29 |
Patent Applications: | 3,782 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ADALAT CC |
What excipients (inactive ingredients) are in ADALAT CC? | ADALAT CC excipients list |
DailyMed Link: | ADALAT CC at DailyMed |
![ADALAT CC drug patent expirations Drug patent expirations by year for ADALAT CC](/p/graph/s/t/ADALAT_CC-patent-expirations.png)
![Drug Prices for ADALAT CC](/p/graph/drug-price/ADALAT+CC.png)
![Drug Sales Revenue Trends for ADALAT CC](/p/graph/drug-sales-revenues/ADALAT+CC.png)
Recent Clinical Trials for ADALAT CC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cao Yu | Phase 1 |
Jing Liu | Phase 4 |
Oregon Health and Science University | Phase 4 |
US Patents and Regulatory Information for ADALAT CC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-001 | Apr 21, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-002 | Apr 21, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-003 | Apr 21, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ADALAT CC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-003 | Apr 21, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-001 | Apr 21, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-002 | Apr 21, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-001 | Apr 21, 1993 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ADALAT CC
See the table below for patents covering ADALAT CC around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Finland | 893544 | ⤷ Sign Up | |
German Democratic Republic | 201974 | VERFAHREN ZUR HERSTELLUNG VON FESTEN ARZNEIZUBEREITUNGEN ENTHALTEND NIFEDIPIN | ⤷ Sign Up |
Denmark | 396381 | ⤷ Sign Up | |
Norway | 157368 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |